Sepio Capital
NVS icon

Sepio Capital’s Novartis NVS Stock Holding History

Sepio Capital’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.51M Sell
10,573
-3,158
-23% -$479K 0.06% 131
2026
Q2 		$2.15M Buy
13,731
+738
+6% +$111K 0.11% 105
2026
Q1 		$1.98M Sell
12,993
-1,034
-7% -$158K 0.11% 117
2025
Q4 		$1.93M Buy
14,027
+476
+4% +$62.3K 0.11% 118
2025
Q3 		$1.74M Buy
13,551
+356
+3% +$43.4K 0.1% 116
2025
Q2 		$1.6M Buy
13,195
+16
+0.1% +$1.8K 0.11% 117
2025
Q1 		$1.47M Sell
13,179
-489
-4% -$52.1K 0.12% 130
2024
Q4 		$1.33M Sell
13,668
-19
-0.1% -$2.03K 0.11% 140
2024
Q3 		$1.57M Sell
13,687
-133
-1% -$15.1K 0.12% 129
2024
Q2 		$1.47M Sell
13,820
-32
-0.2% -$3.21K 0.13% 126
2024
Q1 		$1.34M Sell
13,852
-1,257
-8% -$129K 0.11% 139
2023
Q4 		$1.53M Sell
15,109
-2,071
-12% -$200K 0.13% 117
2023
Q3 		$1.75M Buy
17,180
+939
+6% +$95.3K 0.15% 115
2023
Q2 		$1.64M Sell
16,241
-649
-4% -$64.9K 0.13% 154
2023
Q1 		$1.55M Sell
16,890
-17,250
-51% -$1.51M 0.14% 154
2022
Q4 		$3.1M Sell
34,140
-12,208
-26% -$1.03M 0.27% 101
2022
Q3 		$3.52M Sell
46,348
-2,751
-6% -$228K 0.35% 91
2022
Q2 		$4.15M Sell
49,099
-2,870
-6% -$252K 0.42% 74
2022
Q1 		$4.56M Sell
51,969
-5,703
-10% -$494K 0.4% 82
2021
Q4 		$5.04M Sell
57,672
-1,199
-2% -$100K 0.37% 74
2021
Q3 		$4.81M Buy
58,871
+689
+1% +$62K 0.4% 64
2021
Q2 		$5.31M Sell
58,182
-1,463
-2% -$130K 0.44% 56
2021
Q1 		$5.1M Buy
+59,645
New +$5.35M 0.47% 52
2019
Q3 		– Sell
-24,437
Closed -$2.23M – 270
2019
Q2 		$2.23M Sell
24,437
-3,034
-11% -$257K 0.3% 91
2019
Q1 		$2.37M Sell
27,471
-3,590
-12% -$288K 0.32% 88
2018
Q4 		$2.39M Buy
+31,061
New +$2.42M 0.17% 101

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $77.1B AUM 11.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Cullen Capital Management
Cullen Capital Management New York $9.8B AUM 21.02% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $59.1B AUM 41.96% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Sepio Capital's NVS Position: Q3 2026 in Review

Sepio Capital reduced its Novartis (NVS) stake by 23% in Q3 2026, selling an estimated $479K and leaving 10,573 shares worth $1.51M. The position accounts for 0.06% of the portfolio, ranked #131.

Sepio Capital first reported a position in NVS in Q4 2018 and has held it in 26 quarters since. The position peaked at $5.31M in Q2 2021. 1,212 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Sepio Capital held 10,573 shares of Novartis worth $1.51M as of Q3 2026.
  • Sepio Capital sold 3,158 Novartis shares in Q3 2026, an estimated $479K.
  • Novartis made up 0.06% of Sepio Capital's portfolio in Q3 2026, its #131 holding.
  • Sepio Capital first reported a position in Novartis in Q4 2018 and has held it in 26 quarters since.
  • Sepio Capital's Novartis position peaked at $5.31M in Q2 2021.
  • 1,212 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Sepio Capital's 13F filing for Q3 2026, filed 22 Oct 2026.